Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02789345 |
|---|---|
| Brief Title: | A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer |
| First Submitted : | May 31, 2016 |
| First Submitted that Met QC Criteria : | May 31, 2016 |
| First Posted : | June 3, 2016 (Estimate) |
| Results First Submitted : | May 23, 2023 |
| Results First Submitted that Met QC Criteria : | May 23, 2023 |
| Results First Posted : | February 5, 2024 |
| Last Update Submitted that Met QC Criteria : | May 23, 2023 |
| Last Update Posted : | February 5, 2024 |